Exploring the Evolution of Psychedelic Substances: A Multidisciplinary Perspective from UC Berkeley Professionals
In a recent episode of Berkeley Talks, UC Berkeley professors discussed the evolution of psychedelic substances, their effects on the human brain and mind, and their potential therapeutic role. The panelists included Psychology Professor Gül Dölen, Daniela Kaufer, Noah Whiteman, and Michael Silver.
Dölen emphasized the importance of understanding the state of susceptibility and vulnerability that occurs during psychedelic trips. She likened this to childhood learning experiences and stressed the need to focus on integrating insights gained from these trips into long-term memory networks that support learned behaviors. Dölen also highlighted the importance of providing a safe and supportive environment for individuals during this critical period.
Kaufer spoke about her research on the neurobiology of psychedelics, including their effects on brain connectivity and synaptic plasticity. She also discussed potential applications in mental health treatment, such as for PTSD and depression. Whiteman focused on the role of insects in psychedelic production, specifically discussing the use of psilocybin mushrooms by indigenous cultures for thousands of years. Silver explored the intersection between optics and psychedelia, highlighting how visual perception can be altered by certain compounds.
The event was moderated by Imran Khan, executive director of BCSP, who provided context for each speaker’s contribution to our understanding of psychedelics and their potential impact on society. Overall, this discussion highlights ongoing research in this area at UC Berkeley and underscores the diverse perspectives necessary to fully understand these fascinating substances.
